|
|
Share | Tweet |
Cannabis-Based Pain Med Finally Reaches Canadian Pharmacies
Vancouver, BC - Canada has become the first country in the world to approve the use of a cannabis-based pain medication for use against the pain associated with Multiple Sclerosis.
Sativex was approved for use in Canada last April but it didn't reach pharmacies until now. The medication is administered via a spray which the patient directs under the tongue (sublingual) or on the inside of the cheek. The spray method of pain control (analgesia) offers patients a more flexible method of analgesia as compared to oral medication which must be swallowed. Sublingual medication also has the added benefit of almost instant pain relief. It is available by prescription only.